for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-AstraZeneca Keeping Covid Vaccine In "Drug Substance Format" To Keep Shelf Live - Media Call

Nov 5 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA’S SORIOT SAYS WEEKLY DELIVERY SCHEDULE OF COVID-19 VACCINE WILL ROUGHLY MATCH WHAT UK GOVERNMENT HAS IN MIND FOR VACCINATION PLANS - MEDIA CALL

* ASTRAZENECA’S SORIOT SAYS KEEPING COVID-19 VACCINE IN “DRUG SUBSTANCE FORMAT” TO MAINTAIN SHELF LIVE - MEDIA CALL

* ASTRAZENECA’S SORIOT SAYS IF COVID-19 VACCINE DOES WORK, WILL FILE FOR EMERGENCY APPROVALS IN AS MANY COUNTRIES AS POSSIBLE AT THE SAME TIME

* ASTRAZENECA SAYS CO REMAINS “VERY BULLISH AND POSITIVE” ABOUT THE OUTLOOK FOR CHINA, CONTINUES TO BELIEVE IT CAN GROW AT MID-TEENS RATE IN REGION

* ASTRAZENECA’S SORIOT- UK IS “FULLY PREPARED” TO LAUNCH A COVID-19 VACCINE WHEN IT IS READY, THEY HAVE DONE A “TREMENDOUS JOB” TO GET EVERYTHING LINED UP

* ASTRAZENECA’S SORIOT SAYS WE DON’T KNOW YET HOW LONG COVID-19 VACCINE WILL WORK FOR

* ASTRAZENECA EXEC SAYS CO WILL BE MAKING PROFIT FROM COVID-19 VACCINE AT AN “APPROPRIATE TIME” IN WEALTHY COUNTRIES

* ASTRAZENECA EXECUTIVE PANGALOS SAYS WE HOPE THE COVID-19 VACCINE WILL BE EFFECTIVE FOR AT LEAST A YEAR BUT TRIAL DATA WILL HAVE TO SHOW Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up